Notable Labs, Ltd. NTBLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow NTBLQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '23 | Dec '23 | Mar '24 | Jun '24 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
17.65% | 103.08% | (55.71%) | (79.79%) | |
| 13.64% | (89.92%) | (40.07%) | (59.14%) | ||
ROIC |
0.00% | (263.36%) | (229.58%) | (295.36%) | |
Return on Tangible Assets |
21.00% | (86.33%) | (92.37%) | (219.03%) | |
Average Days of Receivables |
— | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
6.21 | (4.17) | (1.60) | (1.61) | |
Free Cash Flow |
13.91 | (13.78) | (14.42) | (15.20) | |
Capital Expenditures |
8.32 | (0.06) | (0.07) | (0.05) | |
Piotroski F-Score |
— | 2.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
14.30% | (50.42%) | (71.92%) | (131.75%) | |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.16 | 0.00 | 0.00 | |
Inventory Turnover |
— | 0.00 | — | — | |
Average Days of Payables |
0.00 | 3,093.89 | 0.00 | 0.00 | |
Days of Inventory on Hand |
— | 0.00 | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | (4,480.77%) | (3,590.36%) | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | (8,105.77%) | (5,738.55%) | |
Share Based Compensation of Revenue |
0.00% | 0.00% | (581.73%) | (796.39%) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.45 | 1.22 | 1.64 | 1.44 | |
Depreciation/Fixed assets |
— | (1.11) | 1.61 | 1.29 | |
Capex/Depreciation |
0.00 | 0.19 | (0.15) | (0.11) | |
Revenue per Share |
0.00 | 0.00 | (0.01) | (0.02) | |
Operating CF per Share |
2.50 | (4.15) | (1.59) | (1.60) | |
Capex per Share |
3.72 | (0.02) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | (0.64) | (0.30) | |
Net Profit Margin |
0.00% | 0.00% | 8,421.15% | 6,350.60% |
Columns are period end dates